SCHEMBL4012674

SCHEMBL4012674

COCCN(C(C)=O)c1ccc2c(c1)N(C)/C(=C/C(C)=O)S2

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DYRK1A Q13627 10/20 0.47
HTR2A P28223 2/20 0.47
HTR2C P28335 2/20 0.47
CLK1 P49759 9/20 0.44
ALDH1A1 P00352 7/20 0.44
MAPT P10636 6/20 0.44
L3MBTL1 Q9Y468 4/20 0.44
HSD17B10 Q99714 3/20 0.44
CSNK1E P49674 3/20 0.44
CLK3 P49761 3/20 0.44
DYRK1B Q9Y463 3/20 0.44
MEN1 O00255 3/20 0.44
KMT2A Q03164 3/20 0.44
SMN1; SMN2 Q16637 3/20 0.44
NPSR1 Q6W5P4 3/20 0.44
PIM1 P11309 2/20 0.44
CSNK1D P48730 2/20 0.44
CSNK1G2 P78368 2/20 0.44
MAP3K19 Q56UN5 2/20 0.44
PIM3 Q86V86 2/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4012680 1.00 DYRK1A (0.47) DYRK1AHTR2AHTR2CCLK1ALDH1A1
SCHEMBL8033618 0.88 DYRK1A (0.46) DYRK1AHTR2AHTR2CCLK1ALDH1A1
SCHEMBL4012795 0.87 DYRK1A (0.61) DYRK1AHTR2AHTR2CCLK1ALDH1A1
SCHEMBL4012802 0.87 DYRK1A (0.61) DYRK1AHTR2AHTR2CCLK1ALDH1A1
SCHEMBL4018492 0.83 DYRK1A (0.62) DYRK1AHTR2AHTR2CCLK1ALDH1A1
SCHEMBL4018499 0.83 DYRK1A (0.62) DYRK1AHTR2AHTR2CCLK1ALDH1A1
SCHEMBL4017421 0.82 CLK1 (0.63) DYRK1AHTR2AHTR2CCLK1ALDH1A1
SCHEMBL4017411 0.82 CLK1 (0.63) DYRK1AHTR2AHTR2CCLK1ALDH1A1
SCHEMBL4018422 0.79 DYRK1A (0.46) DYRK1AHTR2AHTR2CCLK1ALDH1A1
SCHEMBL4018427 0.79 DYRK1A (0.46) DYRK1AHTR2AHTR2CCLK1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009085226-A2 INHIBITORS OF CDC2-LIKE KINASES (CLKS) AND METHODS OF USE THEREOF SIRTRIS PHARMACEUTICALS, INC. (US) 2009-07-09 WO disclosed
WO-2009085226-A2 INHIBITORS OF CDC2-LIKE KINASES (CLKS) AND METHODS OF USE THEREOF SIRTRIS PHARMACEUTICALS, INC. (US) 2009-07-09 WO disclosed